Haleon (NYSE: HLN) — Company Overview, News & Financial Data
Haleon is a global healthcare company focused on consumer health products, offering over-the-counter medicines and vitamins.
Haleon
Haleon is a global consumer healthcare company focused on providing everyday health products across therapeutic categories including oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Formed through the combination and demerger of the consumer healthcare businesses of GlaxoSmithKline and Pfizer, the company develops and manufactures over-the-counter pharmaceuticals, oral care products, and nutritional supplements. Haleon operates research and development facilities as well as manufacturing units worldwide, distributing its products to retail consumers, pharmacies, and health professionals across more than one hundred countries.
Snapshot
Operations
Products and/or services of Haleon
- Oral Health: Over-the-counter dental hygiene formulations including anti-sensitivity toothpastes, specialist toothbrushes, and denture care products manufactured across dedicated production facilities and supplied through pharmacies, supermarkets, and health channels in more than one hundred countries worldwide.
- Pain Relief: Systemic and topical analgesic treatments including ibuprofen, paracetamol, and anti-inflammatory gels produced for acute pain, joint pain, and migraine management across major North American, European, and Asia-Pacific retail distribution networks.
- Digestive Health and Other: Gastrointestinal and specialty health solutions comprising antacids, acid reducers, and digestive support products supplied globally to retail chains, providing daily symptom relief through varied oral dosage formats and consumer packaging options.
- VMS (Vitamins, Minerals and Supplements): Dietary supplements and multivitamin formulations designed for immune, bone, and daily nutritional support, produced in compliance with global health standards and distributed to consumers across global retail and pharmacy marketplaces.
- Respiratory Health: Decongestant sprays, nasal rinses, antihistamines, and multi-symptom cold and flu treatments manufactured for seasonal allergy, sinus, and respiratory relief, serving consumer markets across North America, Europe, Latin America, and the Asia-Pacific region.
- Manufacturing Facilities: Specialized healthcare manufacturing operations and international distribution hubs supporting high-volume production of oral formulations, creams, tablets, and liquids across multiple specialized production sites located in North America, Europe, and Asia.
Haleon executive team
- Mr. Brian James McNamaraCEO & Executive Director
- Ms. Dawn Amanda AllenCFO & Director
- Ms. Claire DicksonChief Digital & Technology Officer
- Ms. Joanne RussellHead of Investor Relations
- Mr. Adrian Charles MorrisGeneral Counsel
- Ms. Tamara RogersChief Marketing Officer
- Ms. Line De DeckerChief Human Resources Officer
- Mr. Filippo LanziPresident of EMEA & LatAm
- Mr. Keith ChoyPresident of Asia Pacific
- Ms. Lisa PaleyPresident of North America